Related Experiment Video
Updated: May 12, 2026

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery
Christopher B Overgaard1, Vladimír Džavík, Christopher E Buller
1Peter Munk Cardiac Centre, University Heath Network, Toronto, Ontario, Canada.
Insights
For diabetic patients with a totally occluded artery after heart attack, percutaneous coronary intervention (PCI) offers no benefit over optimal medical therapy alone. Diabetes increases cardiovascular risk, but PCI does not improve outcomes in this high-risk group.
Area of Science:
- Cardiology
- Interventional Cardiology
- Diabetology
Background:
- Percutaneous coronary intervention (PCI) for totally occluded arteries post-myocardial infarction (MI) in stable patients does not reduce adverse events.
- Diabetic patients face elevated cardiovascular risk, necessitating specific outcome analysis for PCI versus medical therapy.
Purpose of the Study:
- To evaluate the 7-year clinical outcomes of diabetic patients undergoing PCI versus optimal medical therapy (MED) after MI.
- To compare outcomes between diabetic and non-diabetic patients in the Occluded Artery Trial (OAT).
Main Methods:
- Analysis of 454 diabetic patients randomized to PCI or MED in the OAT.
- Assessment of the composite primary endpoint: death, re-MI, or NYHA class IV heart failure over 7 years.
- Comparison of outcomes between diabetic and non-diabetic cohorts and by treatment strategy.
Main Results:
- Diabetic patients had a significantly higher 7-year primary event rate (35.0%) compared to non-diabetics (19.4%).
- Diabetes was an independent predictor of adverse outcomes, including recurrent MI, heart failure, and death.
- No significant difference in primary event rates between PCI (35.3%) and MED (34.5%) for diabetic patients (p=0.19).
Conclusions:
- PCI does not improve clinical outcomes for diabetic patients with a totally occluded infarct-related artery in the sub-acute phase post-MI.
- Despite higher risks, PCI is not indicated in stable diabetic patients with occluded arteries after MI.
- Optimal medical therapy alone is comparable to PCI in this specific high-risk diabetic population.
Background:
Percutaneous coronary intervention (PCI) of a persistently totally occluded infarct-related artery (IRA) in stable high-risk patients >24h after myocardial infarction (MI) does not reduce the occurrence of death, re-infarction, or heart failure. Diabetic patients are at higher risk for cardiovascular events; we examined their outcomes overall with PCI and optimal medical therapy alone (MED).
Methods:
The long-term (7-year) outcomes of 454 diabetic patients (20.6%) randomized to PCI or MED in the Occluded Artery Trial (OAT) were assessed for the composite primary endpoint of death, re-MI, or New York Heart Association class IV heart failure. Diabetics and non-diabetics were compared and outcomes assessed by treatment strategy.
Results:
The 7-year cumulative primary event rate for diabetic patients was 35.0% vs. 19.4% in the non-diabetic cohort (p<0.001). Multivariable analyses revealed diabetes to be an independent predictor (p<0.01) for the primary outcome, fatal or nonfatal recurrent MI, Class IV Heart Failure (HF), and death. The 7-year cumulative primary event rates were 35.3% in the PCI group vs. 34.5% in the medical therapy group in diabetic patients (p=0.19) and 19.3% in the PCI group vs. 19.5% in the medical therapy group in patients without diabetes (p=0.60).
Conclusions:
Despite the higher overall risk conferred by the presence of diabetes, PCI did not improve clinical outcomes in this subpopulation, and is not indicated in otherwise stable patients with a totally occluded infarct-related artery in the sub-acute phase after MI.
Related Concept Videos
Diabetic Retinopathy
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Diabetic Foot Ulcer